High-yield expression and purification of recombinant human macrophage migration inhibitory factor.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Protein Expression and Purification

• Publication date

  1997-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/PREP.1996.0641PMID 9116493
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of migration inhibitory factor (MIF) by a monoclonal antibody in the microvasculature of inflamed skin

  2004cited by this paper
• MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia

  1995cited by this paper
• Crystallization and a preliminary X-ray diffraction study of macrophage migration inhibitory factor from human lymphocytes.

  1994cited by this paper
• Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF).

  1994cited by this paper
• A diversified family of 12-kDa proteins with a high amino acid sequence similarity to macrophage migration-inhibitory factor (MIF).

  1994cited by this paper
• The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor

  1994cited by this paper
• Purification of macrophage migration inhibitory factor (MIF) from bovine brain cytosol

  1993cited by this paper
• Recombinant migration inhibitory factor induces nitric oxide synthase in murine macrophages.

  1993cited by this paper
• A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens.

  1993cited by this paper
• Purification and characterization of human macrophage migration inhibitory factor: evidence for specific binding to glutathione and formation of subunit structure.

  1993cited by this paper
• Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.

  1993cited by this paper
• Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor.

  1993cited by this paper
• Recombinant human migration inhibitory factor has adjuvant activity.

  1992cited by this paper
• Growth factor-induced delayed early response genes

  1992cited by this paper
• Rat liver protein linking chemical and immunological detoxification systems

  1992cited by this paper
• Human recombinant migration inhibitory factor activates human macrophages to kill Leishmania donovani.

  1991cited by this paper
• Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor.

  1989cited by this paper
• A one-tube plasmid DNA mini-preparation suitable for sequencing.

  1988cited by this paper
• Construction of a plasmid vector for the regulatable high level expression of eukaryotic genes in Escherichia coli: an application to overproduction of chicken lysozyme.

  1987cited by this paper
• Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis

  1987cited by this paper
• Practical aspects of preparing phage and plasmid DNA: growth, maintenance, and storage of bacteria and bacteriophage.

  1987cited by this paper
• Migration inhibitory factor.

  1985cited by this paper
• New M13 vectors for cloning.

  1983cited by this paper
• Estimation of globular protein secondary structure from circular dichroism.

  1981cited by this paper
• Preparative and analytical purification of DNA from agarose.

  1979cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper
• Involvement of lymphocyte mediators in the rejection of a murine tumor allograft.

  1977cited by this paper
• Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells.

  1975cited by this paper
• Macrophage migration from an agarose droplet: development of a micromethod for assay of delayed hypersensitivity.

  1973cited by this paper
• CHARACTERIZATION OF A LYMPHOCYTE FACTOR WHICH ALTERS MACROPHAGE FUNCTIONS

  1973cited by this paper
• Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators.

  1972cited by this paper
• ALTERATIONS OF MACROPHAGE FUNCTIONS BY MEDIATORS FROM LYMPHOCYTES

  1971cited by this paper
• Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.

  1966cited by this paper
• Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity

  1966cited by this paper
• In vitro Studies on Homograft Sensitivity

  1965cited by this paper

• Murine monoclonal antibodies directed against human recombinant Macrophage Migration Inhibitory Factor

  2016cites this paper
• Interaction of macrophage migration inhibitory factor with ceruloplasmin: role of labile copper ions

  2015cites this paper
• Macrophage migration inhibitory factor: Isolation from bovine brain

  2006cites this paper
• Macrophage migration inhibitory factor is a cardiac-derived myocardial depressant factor.

  2003cites this paper
• Macrophage migration inhibitory factor: a critical neurohumoral mediator.

  2002cites this paper
• Homologues of Human Macrophage Migration Inhibitory Factor from a Parasitic Nematode

  2002cites this paper
• Equilibrium and transient intermediates in folding of human macrophage migration inhibitory factor.

  1999cites this paper
• Enzyme Activity of Macrophage Migration Inhibitory Factor toward Oxidized Catecholamines*

  1999cites this paper
• Interaction of macrophage-migration-inhibitory factor with haematin.

  1998cites this paper
• Electrophoretic methods for process monitoring and the quality assessment of recombinant glycoproteins

  1998cites this paper